The present invention relates to polymorphic forms of the compound of FormulaI(i.e., ethyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate (CDDO ethyl ester))and methodsof using them for treating a variety of disease states such as cancer andconditions associatedwith inflammation.(see formula I)